Semaglutide 7·2 mg: another step towards defeating diseases mediated by obesity (original) (raw)
Sattar, Naveed 
ORCID: https://orcid.org/0000-0002-1604-2593 and Lean, Michael E. J. ORCID: https://orcid.org/0000-0003-2216-0083(2025) Semaglutide 7·2 mg: another step towards defeating diseases mediated by obesity.Lancet Diabetes and Endocrinology, 13(11), pp. 901-903. (doi: 10.1016/S2213-8587(25)00262-1) (PMID:40961951)
Abstract
No abstract available.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Sattar, Professor Naveed and Lean, Professor Michael |
| Authors: | Sattar, N., and Lean, M. E. J. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic HealthCollege of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing |
| Journal Name: | Lancet Diabetes and Endocrinology |
| Publisher: | Elsevier |
| ISSN: | 2213-8587 |
| ISSN (Online): | 2213-8595 |
| Published Online: | 14 September 2025 |
| Copyright Holders: | Copyright © 2025 Elsevier |
| First Published: | First published in Lancet Diabetes and Endocrinology13(11):901-903 |
| Publisher Policy: | Reproduced in accordance with the publisher copyright policy |
University Staff: Request a correction | Enlighten Editors: Update this record